139517-52-5

5(4H)-Oxazolone, 4-(diphenylmethylene)-2-phenyl-

1,3,8-Triazaspiro[4.5]decan-4-one,1-(4-fluorophenyl)-8-[(1R,2R)-2-phenylcyclohexyl]-, rel-

Benzeneacetic acid, a-amino-4-(4-fluorophenoxy)-a-methyl-, methylester, (R)-

3-[3-[4-(N-Benzyl-N-methylaminomethyl)-4-hydroxypiperidin-1-yl]propyl]-5-(1,2,4-triazol-4-yl)-1H-indole

2-Pyridinemethanol,4-[5-(3,4-dichlorophenyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]-

1,3,4-Thiadiazole-2(3H)-thione, 5-(2-pyrimidinylamino)-

benzyl 4-(2-(tert-butyldimethylsilyloxy)ethyl)piperazine-1-carboxylate

2H-Quinolizinium, 1-(diphenylmethylene)-5-ethyloctahydro-, bromide

2H-Quinolizinium, 1-(diphenylmethylene)octahydro-5-methyl-, iodide

2-Hexenoic acid, 2-methyl-6-(methylthio)-4,6-dioxo-, ethyl ester, (Z)-

2-Oxazolidinone,3-[(2E,5S,7S)-5,7-dimethyl-1-oxo-2-decenyl]-4-phenyl-, (4R)-

1,4-Heptanedione, 1-(1-cyclopenten-1-yl)-

2-Oxaspiro[3.6]decan-1-one, 3-phenyl-, (3R)-

2-Oxazolamine, 4-(2-thienyl)-

2H-Tetrazole, 2-methyl-5-(2-thiazolyl)-

2H-Tetrazol-5-amine,2-[(2,2,8-trimethyl-4H-1,3-dioxino[4,5-c]pyridin-5-yl)methyl]-

2-Propenoic acid, 3-(dimethylamino)-2-(phenylsulfonyl)-, ethyl ester

2H-Indol-2-one, 1,3-dihydro-3-hydroxy-5-methoxy-3-phenyl-, (3R)-

Sulfamic acid, (3-methylcyclohexyl)-, monosodium salt

2-Pyridinemethanol,4-[[2-[(4-bromophenyl)amino]-1-methyl-1H-benzimidazol-5-yl]oxy]-,trifluoroacetate (salt)

2-Pyridinemethanol, a-phenyl-a-4-piperidinyl-

2H-Quinolizinium, 3-(diphenylmethylene)octahydro-5-methyl-, bromide

2-Propenoic acid, 3-(methylamino)-2-nitro-3-(propylamino)-, compd.with 1-propanamine (1:1)

2H-Pyrrolium, 4-(6-chloro-3-pyridinyl)-5-ethyl-3,4-dihydro-1,2-dimethyl-,(2R,4S)-rel-

2H-Indol-2-one, 1,3-dihydro-3-[[5-(3-nitrophenyl)-2-furanyl]methylene]-

2-Propenoic acid, 3-(dimethylamino)-2-(methylthio)-, ethyl ester

2-Propenoic acid, 3-(methylsulfinyl)-, methyl ester, (2E)-

2-Propenoic acid, 3-(octylsulfinyl)-,29-hydroxy-3,6,9,12,15,18,21,24,27-nonaoxanonacos-1-yl ester

[1,4]Oxazino[3,4-b]quinazolin-6(1H)-one, 3,4-dihydro-1-hydroxy-

2H-Quinolizinium, 2-(diphenylmethylene)octahydro-5-methyl-, iodide

[1,4]Oxazino[3,4-b]quinazolin-6(1H)-one,1-(2-furanylimino)-3,4-dihydro-, (Z)-

2H-Pyran-6-carboxamide,N-[(4-fluorophenyl)methyl]-3,4-dihydro-2-[[4-(hydroxymethyl)phenyl]methoxy]-4-(1-methylethyl)-, (2R,4S)-

2H-Indol-2-one, 1,3-dihydro-3-[(3-methylphenyl)imino]-1-(3-thienyl)-,(3Z)-

2-Propenoic acid, 3-(ethylsulfinyl)-, methyl ester

2-Oxabicyclo[3.2.1]octan-3-one,4-[[(4-hydroxyphenyl)amino]methylene]-1,8,8-trimethyl-, (1R,4Z,5S)-

Benzoic acid, 4-[(1E)-5-cyano-1-pentenyl]-, ethyl ester

2-Propenoic acid, 2-methyl-, 1-ethyl-2,2,3,4,4,4-hexafluorobutyl ester

139517-52-5 msds

CAS No 139517-52-5 supplier

CASNo 139517-52-5 distributor

CAS # 139517-52-5 manufacturer

CAS Number 139517-52-5 safety

CAS RN 139517-52-5 wholesale

2026-10-12 Find 5(4H)-Oxazolone, 4-(diphenylmethylene)-2-phenyl-,CAS No.139517-52-5,Formula:C22H15NO2 in 9CMX